We reported a TP53 germline mutation, c.613T>C (p.Tyr205His) as pathogenic in the patient with metachronous bilateral breast cancer using a multi-gene panel assay myRisk® for hereditary cancer. This evidence concerns the gene TP53 and breast cancer.